Free Trial

AbCellera Biologics (ABCL) SEC Filings & 10K Form

AbCellera Biologics logo
$2.31 -0.05 (-2.12%)
Closing price 04:00 PM Eastern
Extended Trading
$2.34 +0.02 (+1.08%)
As of 06:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent AbCellera Biologics SEC Filings

DateFilerForm TypeView
03/11/2025
5:42 PM
AbCellera Biologics (Issuer)
Thermopylae Holdings Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:11 PM
AbCellera Biologics (Issuer)
Montalbano John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
2:32 PM
AbCellera Biologics (Issuer)
Montalbano John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:36 PM
AbCellera Biologics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:24 PM
AbCellera Biologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
3:11 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
10:56 AM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
2:44 PM
AbCellera Biologics (Issuer)
Stimart Tryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
2:36 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
2:37 PM
AbCellera Biologics (Issuer)
Booth Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
2:40 PM
AbCellera Biologics (Issuer)
Lecault Veronique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:47 PM
AbCellera Biologics (Issuer)
Thermopylae Holdings Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:38 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
9:20 AM
AbCellera Biologics (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SCHEDULE 13G/A
09/24/2024
3:09 PM
AbCellera Biologics (Issuer)
Hansen Carl L. G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:35 PM
AbCellera Biologics (Issuer)
Thermopylae Holdings Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:55 PM
AbCellera Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
3:26 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
5:30 PM
AbCellera Biologics (Issuer)
Hayden Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:38 PM
AbCellera Biologics (Issuer)
Lecault Veronique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:19 PM
AbCellera Biologics (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:15 PM
AbCellera Biologics (Issuer)
Montalbano John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:53 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:22 PM
AbCellera Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:47 PM
AbCellera Biologics (Filer)
Form ARS
04/29/2024
3:39 PM
AbCellera Biologics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ABCL) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners